February 21, 2019 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: Implanet (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, is today announcing it has entered into a Private Label Distribution Agreement with SeaSpine, Inc., a wholly owned subsidiary of SeaSpine Holdings Corporation (NASDAQ: SPNE) covering …